With regards to suicide gene therapy, Rawlinson et al. [27] developed an adenoviral vector carrying the HSV-TK gene under the tumour-specific promoter HE4 and demonstrated increased cell death by prodrug ganciclovir (GCV) treatment in vitro, in ovarian cancer cell lines. Here, TKT is linked to ovarian carcinoma.